Welcome to LookChem.com Sign In|Join Free

CAS

  • or
rac-5-nitro-5-phenyl-piperidin-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1236302-97-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1236302-97-8 Structure
  • Basic information

    1. Product Name: rac-5-nitro-5-phenyl-piperidin-2-one
    2. Synonyms: rac-5-nitro-5-phenyl-piperidin-2-one
    3. CAS NO:1236302-97-8
    4. Molecular Formula:
    5. Molecular Weight: 220.228
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1236302-97-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: rac-5-nitro-5-phenyl-piperidin-2-one(CAS DataBase Reference)
    10. NIST Chemistry Reference: rac-5-nitro-5-phenyl-piperidin-2-one(1236302-97-8)
    11. EPA Substance Registry System: rac-5-nitro-5-phenyl-piperidin-2-one(1236302-97-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1236302-97-8(Hazardous Substances Data)

1236302-97-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1236302-97-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,6,3,0 and 2 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1236302-97:
(9*1)+(8*2)+(7*3)+(6*6)+(5*3)+(4*0)+(3*2)+(2*9)+(1*7)=128
128 % 10 = 8
So 1236302-97-8 is a valid CAS Registry Number.

1236302-97-8Relevant articles and documents

Development of a novel tricyclic class of potent and selective FIXa inhibitors

Meng, Dongfang,Andre, Patrick,Bateman, Thomas J.,Berger, Richard,Chen, Yi-Heng,Desai, Kunal,Dewnani, Sunita,Ellsworth, Kenneth,Feng, Daming,Geissler, Wayne M.,Guo, Liangqin,Hruza, Alan,Jian, Tianying,Li, Hong,Metzger, Joe,Parker, Dann L.,Reichert, Paul,Sherer, Edward C.,Smith, Cameron J.,Sonatore, Lisa M.,Tschirret-Guth, Richard,Wu, Jane,Xu, Jiayi,Zhang, Ting,Campeau, Louis-Charles,Orr, Robert,Poirier, Marc,McCabe-Dunn, Jamie,Araki, Kazuto,Nishimura, Teruyuki,Sakurada, Isao,Hirabayashi, Tomokazu,Wood, Harold B.

, p. 5437 - 5443 (2015)

Using structure based drug design, a novel class of potent coagulation factor IXa (FIXa) inhibitors was designed and synthesized. High selectivity over FXa inhibition was achieved. Selected compounds were evaluated in rat IV/PO pharmacokinetic (PK) studies and demonstrated desirable oral PK profiles. Finally, the pharmacodynamics (PD) of this class of molecules were evaluated in thrombin generation assay (TGA) in Corn Trypsin Inhibitor (CTI) citrated human plasma and demonstrated characteristics of a FIXa inhibitor.

FACTOR IXa INHIBITORS

-

Page/Page column 35; 58, (2016/09/15)

The present invention provides a compound of Formula I and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing unstable angina, refractory angina, myocardial infarction, transient ischemic attacks, atrial fibrillation, thrombotic stroke, embolic stroke, deep vein thrombosis, disseminated intravascular coagulation, ocular build up of fibrin, and reocclusion or restenosis of recanalized vessels. The compounds are selective Factor IXa inhibitors.

3-amido-3-aryl-piperidines: A novel class of potent, selective, and orally active GlyT1 inhibitors

Pinard, Emmanuel,Alberati, Daniela,Alvarez-Sanchez, Ruben,Brom, Virginie,Burner, Serge,Fischer, Holger,Hauser, Nicole,Kolczewski, Sabine,Lengyel, Judith,Mory, Roland,Saladin, Christian,Schulz-Gasch, Tanja,Stalder, Henri

, p. 428 - 433 (2014/05/06)

3-Amido-3-aryl-piperidines were discovered as a novel structural class of GlyT1 inhibitors. The structure-activity relationship, which was developed, led to the identification of highly potent compounds exhibiting excellent selectivity against the GlyT2 isoform, drug-like properties, and in vivo activity after oral administration.

PIPERIDINE DERIVATIVES

-

Page/Page column 26-27, (2010/08/08)

The present invention relates to a compound of formula I wherein R1, R2, and Ar are as defined herein or to a pharmaceutically acceptable acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical iso

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1236302-97-8